Abstract

Crimean-Congo Hemorrhagic Fever (CCHF) is an acute zoonotic viral sickness which originates from Crimean-Congo Hemorrhagic Fever Virus CCHFV and spreads through Hyalomma ticks and infected blood and fluids from affected persons. This potent virus currently exists naturally throughout Africa the Balkans and the Middle East together with some Asian countries and Iraq sees its cases rise because of ecological reasons as well as unrestricted commercial livestock trade. CCHF manifests clinically in two ways from commonplace influenza symptoms to dangerous bleeding complications leading to a high death toll of 40% mortality. Host cell entry and replication take place during its life cycle because ticks connect animals and humans for pathogen transmission. Lab tests using Real- Time Polymerase Chain Reaction RT-PCR and Enzyme Linked Immunosorbent Assay ELISA detect CCHF, and supportive healthcare serves patients including fluid replacement with symptom care. Scientists continue working on vaccine development for the disease since no approved version exists at present. Seasonal spikes in Iraq exist that match the activity patterns of ticks during specific times of the year. Prevention strategies mainly include controlling tick populations and managing livestock management and protecting healthcare workers and actively educating the public. The study emphasizes the need to expedite work on surveillance technologies and vaccines and diagnostic systems to reduce the impact of the disease. The long-term control of CCHF requires integrating One Health programs that unite human health with animal health and environmental health. Controlling CCHF requires a medical and epidemiological approach together with strengthened community support to stop the disease from spreading during ongoing outbreaks.